| Miss Jeannette Marie Figueroa-gordian, MD | |
|
4700 N Habana Ave Ste 101, Tampa, FL 33614-7116 | |
| (813) 444-9599 | |
| (813) 513-8210 |
| Full Name | Miss Jeannette Marie Figueroa-gordian |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Experience | 25 Years |
| Location | 4700 N Habana Ave Ste 101, Tampa, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003979006 | NPI | - | NPPES |
| ACN480 | Other | FL | MEDICAL LICENCE |
| 14424 | Other | PR | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 14424 (Puerto Rico) | Secondary |
| 208D00000X | General Practice | ACN480 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Best Value Healthcare Llc | 2668772419 | 46 |
News Archive
Touch is the first of the five senses to develop, yet scientists know far less about the baby's brain response to touch than to, say, the sight of mom's face, or the sound of her voice.
Heart experts at Johns Hopkins have begun testing a new device designed to replace blocked aortic valves in patients for whom traditional open-heart surgery is considered too risky, such as elderly patients and those with other serious medical conditions.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.
A trial of a novel radioactive compound readily and safely distinguished the brains of Alzheimer's disease patients from healthy volunteers on brain scans and opens the doors to making such imaging available beyond facilities that can manufacture their own radioactive compounds.
› Verified 9 days ago
| Entity Name | Best Value Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790152015 PECOS PAC ID: 2668772419 Enrollment ID: O20151130001070 |
News Archive
Touch is the first of the five senses to develop, yet scientists know far less about the baby's brain response to touch than to, say, the sight of mom's face, or the sound of her voice.
Heart experts at Johns Hopkins have begun testing a new device designed to replace blocked aortic valves in patients for whom traditional open-heart surgery is considered too risky, such as elderly patients and those with other serious medical conditions.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.
A trial of a novel radioactive compound readily and safely distinguished the brains of Alzheimer's disease patients from healthy volunteers on brain scans and opens the doors to making such imaging available beyond facilities that can manufacture their own radioactive compounds.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Jeannette Marie Figueroa-gordian, MD 6675 Westwood Blvd Ste 475, Orlando, FL 32821-6027 Ph: (407) 845-0330 | Miss Jeannette Marie Figueroa-gordian, MD 4700 N Habana Ave Ste 101, Tampa, FL 33614-7116 Ph: (813) 444-9599 |
News Archive
Touch is the first of the five senses to develop, yet scientists know far less about the baby's brain response to touch than to, say, the sight of mom's face, or the sound of her voice.
Heart experts at Johns Hopkins have begun testing a new device designed to replace blocked aortic valves in patients for whom traditional open-heart surgery is considered too risky, such as elderly patients and those with other serious medical conditions.
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.
A trial of a novel radioactive compound readily and safely distinguished the brains of Alzheimer's disease patients from healthy volunteers on brain scans and opens the doors to making such imaging available beyond facilities that can manufacture their own radioactive compounds.
› Verified 9 days ago
Dr. Juan Felipe Ortiz, M.D General Practice Medicare: Accepting Medicare Assignments Practice Location: 4714 N Armenia Ave Ste 100, Tampa, FL 33603 Phone: 813-443-5224 Fax: 813-443-5324 | |
Dr. Gerardo Gomez Cordoba, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 205 W Busch Blvd, Tampa, FL 33612 Phone: 813-514-2333 | |
Carol Blackwood Young, APRN General Practice Medicare: Medicare Enrolled Practice Location: 5112 N Habana Ave, Tampa, FL 33614 Phone: 813-374-2406 | |
Mildred Catherine Conneely, ARNP General Practice Medicare: Medicare Enrolled Practice Location: 1701 W Jetton Ave, Tampa, FL 33606 Phone: 813-786-6364 | |
Dr. Lauren Susan Hendrix, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 3030 North Rocky Point Drive West, Suite 670, Tampa, FL 33607 Phone: 813-289-6597 Fax: 813-289-6592 | |
Dr. Albert Matos Guadalupe, General Practice Medicare: Medicare Enrolled Practice Location: 400 E Dr Martin Luther King Jr Blvd, Tampa, FL 33603 Phone: 813-308-4040 |